Which groundbreaking medical product, launched in 2014, combined a long-acting insulin with a GLP-1 receptor agonist in a single injection for the first time?

The pharmaceutical industry has seen numerous groundbreaking product launches that have revolutionized patient care. These medical innovations have not only transformed treatment protocols but have also created billion-dollar revenue streams for their developers. This trivia question tests your knowledge about a significant product launch that changed the landscape of diabetes treatment and created a new paradigm in medication delivery systems.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Xultophy (insulin degludec/liraglutide)
Lantus SoloStar (insulin glargine)
Ozempic (semaglutide)
Toujeo (insulin glargine U-300)